196 related articles for article (PubMed ID: 36908789)
1. Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in Parkinson's disease.
Tong SY; Wang RW; Li Q; Liu Y; Yao XY; Geng DQ; Gao DS; Ren C
Front Neurosci; 2023; 17():1136499. PubMed ID: 36908789
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of glial cell line-derived neurotrophic factor and multiple neurotransmitters: In relation to cognitive performance in Parkinson's disease with mild cognitive impairment.
Liu Y; Tong S; Ding L; Liu N; Gao D
Int J Geriatr Psychiatry; 2020 Feb; 35(2):153-162. PubMed ID: 31650626
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
[TBL] [Abstract][Full Text] [Related]
4. Possible role of glial cell line-derived neurotrophic factor for predicting cognitive impairment in Parkinson's disease: a case-control study.
Shi MY; Ma CC; Chen FF; Zhou XY; Li X; Tang CX; Zhang L; Gao DS
Neural Regen Res; 2021 May; 16(5):885-892. PubMed ID: 33229724
[TBL] [Abstract][Full Text] [Related]
5. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
Cammisuli DM; Sportiello MT
Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
[TBL] [Abstract][Full Text] [Related]
6. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
[TBL] [Abstract][Full Text] [Related]
7. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
9. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
[TBL] [Abstract][Full Text] [Related]
10. Impairment of the visuospatial working memory in the patients with Parkinson's Disease: an fMRI study.
Kawashima S; Shimizu Y; Ueki Y; Matsukawa N
BMC Neurol; 2021 Sep; 21(1):335. PubMed ID: 34479502
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
12. Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson's Disease with Sleep Disorders.
Wang L; Gao Z; Chen G; Geng D; Gao D
Brain Sci; 2023 Jan; 13(2):. PubMed ID: 36831743
[TBL] [Abstract][Full Text] [Related]
13. Correlation of MRI Visual Scales with Neuropsychological Profile in Mild Cognitive Impairment of Parkinson's Disease.
Vasconcellos LF; Pereira JS; Adachi M; Greca D; Cruz M; Malak AL; Charchat-Fichman H; Spitz M
Parkinsons Dis; 2017; 2017():7380102. PubMed ID: 28409050
[TBL] [Abstract][Full Text] [Related]
14. Altered Prefrontal Blood Flow Related With Mild Cognitive Impairment in Parkinson's Disease: A Longitudinal Study.
Wang J; Zhang W; Zhou Y; Jia J; Li Y; Liu K; Ye Z; Jin L
Front Aging Neurosci; 2022; 14():896191. PubMed ID: 35898326
[TBL] [Abstract][Full Text] [Related]
15. The severity of executive dysfunction among different PD-MCI subtypes.
Kormas C; Zalonis I; Evdokimidis I; Kapaki E; Potagas C
Appl Neuropsychol Adult; 2022; 29(4):546-550. PubMed ID: 32633669
[TBL] [Abstract][Full Text] [Related]
16. Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder.
Zhang X; Ru B; Sha W; Xin W; Zhou H; Zhang Y
Asia Pac Psychiatry; 2014 Sep; 6(3):302-7. PubMed ID: 24436216
[TBL] [Abstract][Full Text] [Related]
17. Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson's disease.
Tang CX; Chen J; Shao KQ; Liu YH; Zhou XY; Ma CC; Liu MT; Shi MY; Kambey PA; Wang W; Ayanlaja AA; Liu YF; Xu W; Chen G; Wu J; Li X; Gao DS
Neural Regen Res; 2023 May; 18(5):1107-1117. PubMed ID: 36255000
[TBL] [Abstract][Full Text] [Related]
18. Distinct serum GDNF coupling with brain structural and functional changes underlies cognitive status in Parkinson's disease.
Tang C; Sun R; Xue K; Wang M; Liang S; Kambey PA; Shi M; Wu C; Chen G; Gao D
CNS Neurosci Ther; 2024 Mar; 30(3):e14461. PubMed ID: 37718594
[TBL] [Abstract][Full Text] [Related]
19. Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment.
Stefani A; Pierantozzi M; Olivola E; Galati S; Cerroni R; D'Angelo V; Hainsworth AH; Saviozzi V; Fedele E; Liguori C
Neurochem Int; 2017 May; 105():58-63. PubMed ID: 28108196
[TBL] [Abstract][Full Text] [Related]
20. Rapid Eye Movement Sleep Behavior Disorder Symptoms Correlate with Domains of Cognitive Impairment in Parkinson's Disease.
Zhang JR; Chen J; Yang ZJ; Zhang HJ; Fu YT; Shen Y; He PC; Mao CJ; Liu CF
Chin Med J (Engl); 2016 Feb; 129(4):379-85. PubMed ID: 26879009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
